St. Louis-based Mercy recorded an operating income of $230.3 million (2.8% margin) through the third quarter of fiscal 2026, up from an operating loss of $57 million (-0.8% margin) through the same period last year, according to its June 2 financial report.
Four things to know:
1. Mercy reported total operating revenue of $8.1 billion through the nine months ended March 31, an 8.1% increase year over year. Patient service revenue increased 8.6% year over year to $7.4 billion, resulting from higher volumes and contracted rate improvements. Total patient discharges were 1.8% higher than the prior year.
2. Total operating expenses were $7.9 billion through Q3 2026, a 4.2% increase year over year. Salaries and benefits totaled $4.3 billion, a 0.4% increase year over year. Supplies and other expenses totaled $3.1 billion, an 11% increase.
3. Acute patient days increased 0.9% year over year. Acute length of stay was 3.9 days, compared to 4 days during the same period last year. Outpatient visits increased 19.1% year over year. Surgeries and emergency room visits were up 7.3% and 3.5%, respectively, from the prior year. Clinic visits were also up 7.3%. Mercy said these metrics increased due to an intentional effort around patient access.
4. Mercy reported a net income of $538.5 million through Q3 2026, up from a net income of $74.2 million during the same period last year.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
